| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yuan Cao, Wen Yao, Fang Che. Brief research report: WGCNA-driven identification of histone modification genes as potential biomarkers in AQP4-Associated optic neuritis. Frontiers in genetics. vol 15. 2024-09-06. PMID:39238786. |
the discovery of antibodies aqp4 and myelin oligodendrocyte glycoprotein (mog) has expanded our understanding of the pathogenesis of neuromyelitis optica. |
2024-09-06 |
2024-09-08 |
Not clear |
| Ruth Geraldes, Georgina Arrambide, Brenda Banwell, Àlex Rovira, Rosa Cortese, Hans Lassmann, Silvia Messina, Mara Assunta Rocca, Patrick Waters, Declan Chard, Claudio Gasperini, Yael Hacohen, Romina Mariano, Friedemann Paul, Gabriele C DeLuca, Christian Enzinger, Ludwig Kappos, M Isabel Leite, Jaume Sastre-Garriga, Tarek Yousry, Olga Ciccarelli, Massimo Filippi, Frederik Barkhof, Jacqueline Palac. The influence of MOGAD on diagnosis of multiple sclerosis using MRI. Nature reviews. Neurology. 2024-09-03. PMID:39227463. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is an immune-mediated demyelinating disease that is challenging to differentiate from multiple sclerosis (ms), as the clinical phenotypes overlap, and people with mogad can fulfil the current mri-based diagnostic criteria for ms. |
2024-09-03 |
2024-09-06 |
Not clear |
| Yanan Ding, Li Zhang, Anqi Huang, Xianyue Meng, Xueli L. A Confused Case Diagnosed as Cerebral Infarction or Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Case reports in neurological medicine. vol 2024. 2024-09-02. PMID:39220233. |
in order to discuss the clinical and mri features, diagnosis, and prevention of myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), we reported an adult case of mog antibody-related disease misdiagnosed as cerebral infarction. |
2024-09-02 |
2024-09-04 |
Not clear |
| Ryoko Shibuya, Risako Furuta, Ryo Tanaka, Takamasa Nukui, Shunya Nakane, Yuji Nakatsuj. [Anti-myelin oligodendrocyte glycoprotein (MOG) antibody-associated cortical encephalitis with low signal in subcortical white matter on MRI FLAIR imaging]. Rinsho shinkeigaku = Clinical neurology. 2024-08-28. PMID:39198158. |
[anti-myelin oligodendrocyte glycoprotein (mog) antibody-associated cortical encephalitis with low signal in subcortical white matter on mri flair imaging]. |
2024-08-28 |
2024-09-01 |
Not clear |
| Ryoko Shibuya, Risako Furuta, Ryo Tanaka, Takamasa Nukui, Shunya Nakane, Yuji Nakatsuj. [Anti-myelin oligodendrocyte glycoprotein (MOG) antibody-associated cortical encephalitis with low signal in subcortical white matter on MRI FLAIR imaging]. Rinsho shinkeigaku = Clinical neurology. 2024-08-28. PMID:39198158. |
the clinical presentation and mri findings raised suspicions of myelin oligodendrocyte glycoprotein (mog) antibody-associated cortical encephalitis. |
2024-08-28 |
2024-09-01 |
Not clear |
| Emily Guagliardo, Divya Singh, Jasmine Thakkar, Wilson Rodriguez, Francesca Pastrana, Hanan Qaqish, Pratap Chan. Reversible Bilateral Vision Loss: An Unusual Presentation of Wernicke-Korsakoff Syndrome. Cureus. vol 16. issue 7. 2024-08-16. PMID:39149664. |
the patient was also later found to have a positive anti-myelin oligodendrocyte glycoprotein (mog) antibody, which was deemed false positive given the atypical phenotype and symptomatic improvement with thiamine supplementation. |
2024-08-16 |
2024-08-18 |
Not clear |
| Jianhang He, Xiaoyan Niu, Xiaoyan Chen, Boya Ma, Yazhou Ren, Weimin Qi, Xiuping Zhan, Yue Meng, Jianxia Li, Haining L. Overlapping syndrome of anti-MOG antibody-associated disease and anti-mGluR5 encephalitis manifested as optic neuritis: A case report. Medicine. vol 103. issue 33. 2024-08-16. PMID:39151524. |
anti-myelin oligodendrocyte glycoprotein (mog) and anti-metabotropic glutamate receptor 5 (mglur5) double antibody positive encephalitis characterized by optic neuritis is extremely rare. |
2024-08-16 |
2024-08-20 |
Not clear |
| Armin Handzic, Jim Shenchu Xie, Nanthaya Tisavipat, Roisin Maire O'Cearbhaill, Deena A Tajfirouz, Kevin D Chodnicki, Eoin P Flanagan, John J Chen, Jonathan Micieli, Edward Margoli. Radiological predictors of visual outcome in myelin oligodendrocyte glycoprotein-related optic neuritis. Ophthalmology. 2024-08-16. PMID:39151754. |
this study aimed to determine whether magnetic resonance imaging (mri) biomarkers are associated with visual prognosis in myelin oligodendrocyte protein (mog)-associated optic neuritis (mog-on). |
2024-08-16 |
2024-08-20 |
Not clear |
| Debamita Datta, Mala Mahto, Upasna Sinha, Sushil Kuma. Indirect Immunofluorescence-Aided Detection of Antimyelin Oligodendrocyte Glycoprotein Antibodies in Neuromyelitis Optica Spectrum Disorder/Myelin Oligodendrocyte Glycoprotein-Associated Antibody Disorder: A Case Series Involving Five Patients. Annals of African medicine. 2024-08-14. PMID:39138928. |
in contrast to aqp-4 abs, myelin oligodendrocyte glycoprotein (mog) abs are detected in some patients exhibiting nonmotor cognitive impairment. |
2024-08-14 |
2024-08-16 |
Not clear |
| Fan-Ya Sun, Jia Shen, Le Ding, Bo Zhu, Naibing Gu, Zhiqin Liu, Zhengli Di, Xiao-Tao Ji. Bilateral pontine brachium lesions in one autoantibodies directed against MOG positive patient: A case report. Medicine. vol 103. issue 32. 2024-08-09. PMID:39121314. |
myelin oligodendrocyte glycoprotein (mog) antibody-related disease is a relatively recent entity in inflammatory demyelinating disease. |
2024-08-09 |
2024-08-12 |
Not clear |
| Richard K Burt, Joachim Burman, Raffaella Greco, John W Ros. Hematopoietic stem cell transplantation for neuromyelitis optica spectrum disorder. Can immune tolerance be reestablished? Handbook of clinical neurology. vol 202. 2024-08-07. PMID:39111907. |
more recently, nmosd has been subdivided according to auto-antibody status as aquaporin 4 (aqp4) seropositive nmo, myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad), and seronegative nmosd. |
2024-08-07 |
2024-08-10 |
rabbit |
| Luca Bernardi, Nicole Mussi, Roberto Grandinetti, Emanuela Turco, Benedetta Piccolo, Francesca Ormitti, Nicola Principi, Susanna Esposit. FLAIR Hyperintense Cortical Lesions in a 4-Year-Old Child with Myelin Oligodendrocyte Glycoprotein (MOG)-Associated Encephalitis and Seizures: A Case Report. Children (Basel, Switzerland). vol 11. issue 7. 2024-07-27. PMID:39062226. |
flair hyperintense cortical lesions in a 4-year-old child with myelin oligodendrocyte glycoprotein (mog)-associated encephalitis and seizures: a case report. |
2024-07-27 |
2024-07-29 |
Not clear |
| Luca Bernardi, Nicole Mussi, Roberto Grandinetti, Emanuela Turco, Benedetta Piccolo, Francesca Ormitti, Nicola Principi, Susanna Esposit. FLAIR Hyperintense Cortical Lesions in a 4-Year-Old Child with Myelin Oligodendrocyte Glycoprotein (MOG)-Associated Encephalitis and Seizures: A Case Report. Children (Basel, Switzerland). vol 11. issue 7. 2024-07-27. PMID:39062226. |
myelin oligodendrocyte glycoprotein (mog)-igg-associated disease (mogad) is a relatively uncommon autoantibody demyelinating disorder of the central nervous system (cns) with heterogeneous clinical manifestations and magnetic resonance imaging (mri) findings. |
2024-07-27 |
2024-07-29 |
Not clear |
| Meng-Meng Wang, Tao Huang, Jia-Xun Li, Yang Yao, Ying Chen, Kai-Kai Fu, Wen-Rong Miao, Yi Ha. Optic Neuritis Leading to Vision Loss: A Case of MOG-Associated Disease with Successful Immunotherapy. The American journal of case reports. vol 25. 2024-07-26. PMID:39054886. |
background myelin oligodendrocyte glycoprotein (mog)-associated disease (mogad) is a recently described inflammatory demyelinating disease of the central nervous system (cns), which needs to be distinguished from aquaporin-4 (aqp4)-igg-positive neuromyelitis optica spectrum disorder (aqp4-igg+nmosd) and multiple sclerosis (ms). |
2024-07-26 |
2024-07-28 |
Not clear |
| Mary Karalius, Sonam Mohan, Danelvis Paredes, Nailyn Rasool, Riley Bov. Pearls & Oy-sters: Optic Neuritis as First Demyelinating Event During Pregnancy in 2 Young Hispanic Women: MS vs MOGAD. Neurology. vol 103. issue 4. 2024-07-25. PMID:39052965. |
optic neuritis (on) can present as the first demyelinating attack in both multiple sclerosis (ms) and myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad), which may require different treatment depending on the final diagnosis. |
2024-07-25 |
2024-07-28 |
Not clear |
| Sara Samadzadeh, Rafl Adnan, Paulina Berglova, Mahdi Barzegar, Birgit Debrabant, Stine Gundtoft Roikjaer, Michael Levy, Axel Petzold, Jacqueline Palace, Eoin P Flanagan, Sara Mariotto, Soeren T Skou, Anne Froelich, Itay Lotan, Silvia Messina, Ruth Geraldes, Susanna Asseyer, Hadas Stiebel-Kalish, Frederike Cosima Oertel, Vahid Shaygannejad, Mohammad Ali Sahraian, Ho Jin Kim, Jeffrey L Bennett, Chotima Böttcher, Hanna G Zimmermann, Brian G Weinshenker, Friedemann Paul, Nasrin Asgar. Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT). Frontiers in immunology. vol 15. 2024-07-18. PMID:39021565. |
comorbidities in patients with multiple sclerosis (ms) and antibody-mediated diseases of the central nervous system (cns) including neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein (mog)-antibody-associated disease (mogad) are common and may influence the course of their neurological disease. |
2024-07-18 |
2024-07-20 |
human |
| Carson E Moseley, Akash Virupakshaiah, Thomas G Forsthuber, Lawrence Steinman, Emmanuelle Waubant, Scott S Zamvi. MOG CNS Autoimmunity and MOGAD. Neurology(R) neuroimmunology & neuroinflammation. vol 11. issue 5. 2024-07-12. PMID:38996203. |
at one time considered a possible form of neuromyelitis optica (nmo) spectrum disorder (nmosd), it is now accepted that myelin oligodendrocyte glycoprotein (mog) antibody (ab)-associated disorder (mogad) is a distinct entity from either nmo or multiple sclerosis (ms) and represents a broad spectrum of clinical phenotypes. |
2024-07-12 |
2024-07-15 |
Not clear |
| Jodie M Burton, Saerom Youn, Abdullah Al-Ani, Fiona Costell. Correction to: Patterns and utility of myelin oligodendrocyte glycoprotein (MOG) antibody testing in cerebrospinal fluid. Journal of neurology. 2024-07-05. PMID:38969877. |
correction to: patterns and utility of myelin oligodendrocyte glycoprotein (mog) antibody testing in cerebrospinal fluid. |
2024-07-05 |
2024-07-08 |
Not clear |
| María Dema, Herena Eixarch, Mireia Castillo, Xavier Montalban, Carmen Espej. IL-6 Inhibition as a Therapeutic Target in Aged Experimental Autoimmune Encephalomyelitis. International journal of molecular sciences. vol 25. issue 12. 2024-06-27. PMID:38928437. |
young and aged mice were immunized with myelin oligodendrocyte protein (mog) |
2024-06-27 |
2024-06-29 |
mouse |
| Y K Ananya, L Ramy. Deciphering the conformational dynamics of Myelin Oligodendrocyte glycoprotein in the myelin sheath. Journal of biomolecular structure & dynamics. 2024-06-24. PMID:38910432. |
myelin oligodendrocyte glycoprotein (mog) is a transmembrane protein in the myelin sheath. |
2024-06-24 |
2024-06-26 |
human |